Our work on Cystic Fibrosis
Cystic Fibrosis is a rare genetic disease characterised by excessive production of thick mucus primarily affecting the lungs and digestive system.
Patients with this condition experience breathing difficulties, frequent lung infections, and digestive problems that affect their daily quality of life.
CF-Monitor
WHAT WE BUILT
CF-Monitor is a tool used to objectively and continuously monitor key functions affected by Cystic Fibrosis.
FEATURED TESTS
HOW IT'S USED
• 1 research study in Europe
• 1 observational study in France
SUPPORTED BY
Ad Scientiam
Advanced Data Research
THE CHALLENGE
This progressive and complex disease poses a challenge when monitoring clinical evolution, particularly for optimizing treatments and improving patients' quality of life.
Objective monitoring of lung function outside medical consultations is limited
Doctors rely on point-in-time measurements during consultations, which presents a lack of continuous data that can compromise early detection of exacerbations and optimal treatment adjustments.
Symptoms vary considerably daily in Cystic Fibrosis
Clinical assessments performed during consultations may not reflect the real state of the patient as symptoms fluctuate in their daily lives.
